- Home
- PTNM vs SLN Comparison
PTNM vs SLN Comparison
Compare PTNM & SLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTNM
- SLN
- Stock Information
- Founded
- PTNM 2013
- SLN 1994
- Country
- PTNM Hong Kong
- SLN United Kingdom
- Employees
- PTNM N/A
- SLN N/A
- Industry
- PTNM
- SLN Biotechnology: Pharmaceutical Preparations
- Sector
- PTNM
- SLN Health Care
- Exchange
- PTNM Nasdaq
- SLN Nasdaq
- Market Cap
- PTNM 320.2M
- SLN 299.4M
- IPO Year
- PTNM 2025
- SLN N/A
- Fundamental
- Price
- PTNM $1.85
- SLN $4.81
- Analyst Decision
- PTNM
- SLN Buy
- Analyst Count
- PTNM 0
- SLN 5
- Target Price
- PTNM N/A
- SLN $32.60
- AVG Volume (30 Days)
- PTNM 3.3M
- SLN 61.8K
- Earning Date
- PTNM 01-01-0001
- SLN 08-07-2025
- Dividend Yield
- PTNM N/A
- SLN N/A
- EPS Growth
- PTNM N/A
- SLN N/A
- EPS
- PTNM 0.05
- SLN N/A
- Revenue
- PTNM $9,644,233.00
- SLN $27,169,000.00
- Revenue This Year
- PTNM N/A
- SLN N/A
- Revenue Next Year
- PTNM N/A
- SLN N/A
- P/E Ratio
- PTNM $32.65
- SLN N/A
- Revenue Growth
- PTNM 9.87
- SLN 22.28
- 52 Week Low
- PTNM $0.98
- SLN $1.97
- 52 Week High
- PTNM $14.79
- SLN $20.48
- Technical
- Relative Strength Index (RSI)
- PTNM N/A
- SLN 34.88
- Support Level
- PTNM N/A
- SLN $4.91
- Resistance Level
- PTNM N/A
- SLN $5.34
- Average True Range (ATR)
- PTNM 0.00
- SLN 0.48
- MACD
- PTNM 0.00
- SLN -0.05
- Stochastic Oscillator
- PTNM 0.00
- SLN 0.71
About PTNM Pitanium Limited Class A Ordinary shares
Pitanium Ltd is a retailer in Hong Kong focusing on the sale of its proprietary brand of skincare and personal care products, especially haircare products, namely PITANIUM and BIG PI online and offline with six retail stores situated in Prime shopping destinations in Hong Kong. The company emphasizes product design and development with an in-house product development team working closely with its original equipment manufacturing (OEM) and original design manufacturing (ODM) suppliers.
About SLN Silence Therapeutics Plc American Depository Share
Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.